Yeungnam University College Of Medicine
Clinical trials sponsored by Yeungnam University College Of Medicine, explained in plain language.
-
New eye drug regimen could mean fewer shots for PCV patients
Disease control Recruiting nowThis study tests a higher dose of the eye medication aflibercept (8 mg) given on a personalized schedule for people with a specific type of wet macular degeneration called polypoidal choroidal vasculopathy (PCV). The goal is to see if this approach can safely extend the time betw…
Phase: PHASE3 • Sponsor: Yeungnam University College of Medicine • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
New eye drug regimen aims to extend time between treatments for PCV patients
Disease control Recruiting nowThis study is testing a personalized treat-and-extend approach using faricimab for people newly diagnosed with polypoidal choroidal vasculopathy (PCV), a form of age-related macular degeneration. The goal is to see if this regimen can control the disease while allowing longer int…
Phase: PHASE3 • Sponsor: Yeungnam University College of Medicine • Aim: Disease control
Last updated May 22, 2026 14:05 UTC